Obesity is associated with metabolic dysfunction and hyperinsulinemia, resulting in increased synthesis of insulin-like growth factor-1 (IGF-1), which activates the PI3K and MAPK signaling pathways, leading to cancer cell proliferation and survival. Here, IGF1 is linked to hyperinsulinism.